Gender differences in pulmonary arterial hypertension patients with BMPR2 mutation: a meta-analysis
Authors:
Open Access
- 6 February 2020
- journal article
- research article
- Published by Springer Nature in Respiratory Research
- Vol. 21 (1) , 1-10
Abstract
Objective: To investigate the differences in the proportions of BMPR2 mutations in familial hereditary pulmonary arterial hypertension (HPAH) and idiopathic pulmonary arterial hypertension (IPAH) between males and females and the relationship between BMPR2 mutation and PAH severity.Methods: A computer was used to search the electronic Cochrane Library, PubMed/MEDLINE, and EMBASE databases for clinical trials containing information on the relationship between PAH prognosis and BMPR2 mutations through March 2019. After obtaining the data, a meta-analysis was performed using Review Manager Version 5.3 and Stata.Results: A meta-analysis was performed on 17 clinical trials (2198 total patients: 644 male, 1554 female). The results showed that among patients with HPAH and IPAH, the BMPR2 mutation rate is higher in male than in female patients [male group (224/644, 34.78%), female group (457/1554, 29.41%), OR = 1.30, 95% CI: 1.06~1.60,P = 0.01, I2 = 10%]. Furthermore, haemodynamic and functional parameters were more severe in IPAH and HPAH patients with BMPR2 mutations than in those without, and those with BMPR2 mutation were diagnosed at a younger age. The risk of death or transplantation was higher in PAH patients with BMPR2 mutations than in those without (OR = 2.51, 95% CI: 1.29~3.57,P = 0.003, I2 = 24%). Furthermore, the difference was significant only in male patients (OR = 5.58, 95% CI: 2.16~14.39,P = 0.0004, I2 = 0%) and not in female patients (OR = 1.41, 95% CI: 0.75~2.67,P = 0.29, I2 = 0%).Conclusion: Among patients with HPAH and IPAH, men are more likely to have BMPR2 mutations, which may predict more severe PAH indications and prognosis.Keywords
Funding Information
- National Natural Science Foundation of China (81960015, 81800051)
- Youth Science Foundation from the Science and Technology Department of Jiangxi province (20171BAB215002, 20171BAB215040, 20161BAB215251)
This publication has 46 references indexed in Scilit:
- BMPR2 Mutations Influence Phenotype More Obviously in Male Patients With Pulmonary Arterial HypertensionCirculation: Cardiovascular Genetics, 2012
- The Estrogen Puzzle in Pulmonary Arterial HypertensionCirculation, 2012
- Outcomes of Childhood Pulmonary Arterial Hypertension in BMPR2 and ALK1 Mutation CarriersThe American Journal of Cardiology, 2012
- BMPR2 expression is suppressed by signaling through the estrogen receptorBiology of Sex Differences, 2012
- Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutationsRespiratory Research, 2011
- Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertensionRespiratory Research, 2010
- Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertensionRespiratory Research, 2009
- Clinical Implications of Determining BMPR2 Mutation Status in a Large Cohort of Children and Adults With Pulmonary Arterial HypertensionThe Journal of Heart and Lung Transplantation, 2008
- Relationship of BMPR2 Mutations to Vasoreactivity in Pulmonary Arterial HypertensionCirculation, 2006
- Genetic basis of pulmonary arterial hypertensionJACC, 2004